TY - JOUR
T1 - Association of 6% hetastarch resuscitation with adverse outcomes in critically ill trauma patients
AU - Lissauer, Matthew E.
AU - Chi, Albert
AU - Kramer, Mary E.
AU - Scalea, Thomas M.
AU - Johnson, Steven B.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2011/7
Y1 - 2011/7
N2 - Background Six percent hetastarch is used as a volume expander but has been associated with poor outcomes. The aim of this study was to evaluate trauma patients resuscitated with hetastarch. Methods A retrospective review was performed of adult trauma patients. Demographics, injury severity, laboratory values, outcomes, and hetastarch use were recorded. Results A total of 2,225 patients were identified, of whom 497 (22%) received hetastarch. There were no differences in age, gender, injury mechanism, lactate, hematocrit, or creatinine. The mean injury severity score was different: 29.7 ± 12.6 with hetastarch versus 27.5 ± 12.6 without hetastarch. Acute kidney injury developed in 65 hetastarch patients (13%) and in 131 (8%) without hetastarch (relative risk, 1.73; 95% confidence interval [CI], 1.30-2.28). Hetastarch mortality was 21%, compared with 11% without hetastarch (relative risk, 1.84; 95% CI, 1.48-2.29). Multivariate logistic regression demonstrated hetastarch use (odds ratio, 1.96; 95% CI, 1.49-2.58) as independently significant for death. Hetastarch use was independently significant for renal dysfunction as well (odds ratio, 1.70; 95% CI, 1.22-2.36). Conclusions Because of the detrimental association with renal function and mortality, hetastarch should be avoided in the resuscitation of trauma patients.
AB - Background Six percent hetastarch is used as a volume expander but has been associated with poor outcomes. The aim of this study was to evaluate trauma patients resuscitated with hetastarch. Methods A retrospective review was performed of adult trauma patients. Demographics, injury severity, laboratory values, outcomes, and hetastarch use were recorded. Results A total of 2,225 patients were identified, of whom 497 (22%) received hetastarch. There were no differences in age, gender, injury mechanism, lactate, hematocrit, or creatinine. The mean injury severity score was different: 29.7 ± 12.6 with hetastarch versus 27.5 ± 12.6 without hetastarch. Acute kidney injury developed in 65 hetastarch patients (13%) and in 131 (8%) without hetastarch (relative risk, 1.73; 95% confidence interval [CI], 1.30-2.28). Hetastarch mortality was 21%, compared with 11% without hetastarch (relative risk, 1.84; 95% CI, 1.48-2.29). Multivariate logistic regression demonstrated hetastarch use (odds ratio, 1.96; 95% CI, 1.49-2.58) as independently significant for death. Hetastarch use was independently significant for renal dysfunction as well (odds ratio, 1.70; 95% CI, 1.22-2.36). Conclusions Because of the detrimental association with renal function and mortality, hetastarch should be avoided in the resuscitation of trauma patients.
KW - Hetastarch
KW - Shock/hemorrhage
KW - Traumatology
KW - Wounds and injuries
UR - http://www.scopus.com/inward/record.url?scp=79960185226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960185226&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2010.05.002
DO - 10.1016/j.amjsurg.2010.05.002
M3 - Article
C2 - 21600555
AN - SCOPUS:79960185226
SN - 0002-9610
VL - 202
SP - 53
EP - 58
JO - American journal of surgery
JF - American journal of surgery
IS - 1
ER -